Skip to main content


  • Sunday, Aug 24th
    10:45 AM - 11:00 AM ET
    1D-02 - Risk of Incident Supraventricular Tachycardia Following Exposure to Recombinant Zoster Vaccine in Adults ≥50 Years of Age in the United States
    Co-Author: Sophie E. Mayer, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
    Co-Author: Sarah Alam – Department of Population Medicine, Harvard Pilgrim Health Care Institute
    Co-Author: Alexander Peters – Department of Population Medicine, Harvard Pilgrim Health Care Institute
    Co-Author: Elizabeth Messenger-Jones, MSPH – Department of Population Medicine, Harvard Pilgrim Health Care Institute
    Co-Author: Dongdong Li, PhD, MS – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
    Co-Author: Richard Platt, MD, MSc – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
    Co-Author: Belal Suleiman, MD – Duke University Health
    Co-Author: Christopher B. Granger, MD – Duke University Health
    Co-Author: Erick Moyneur, MA – StatLog
    Co-Author: Qianli Ma – Humana Healthcare Research
    Co-Author: Mano Selvan, PhD – Humana Healthcare Research
    Co-Author: Rachel P. Ogilvie, PhD, MPH – Optum
    Co-Author: Najat J. Ziyadeh – Optum
    Co-Author: Kimberly Daniels, PhD, MS – Carelon Research
    Co-Author: Anna E. Wentz, PhD – Carelon Research
    Co-Author: Djeneba Audrey Djibo, PhD – CVS Health
    Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – Glade Oak Inc
    Co-Author: Driss Oraichi – GSK
    Co-Author: Harry Seifert – GSK
    Co-Author: Valentine Franck – GSK
    Co-Author: Huifeng Yun – GSK, Rockville, MD, USA
    Co-Author: O'Mareen Spence, PhD – GSK
    Presenting Author: Sheryl A. Kluberg, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
    Pharmacovigilance / Cardiovascular
  • Monday, Aug 25th
    8:50 AM - 8:55 AM ET
    3C-06 - Mortality and hospitalization rates of adults with stable, chronic heart failure with reduced ejection fraction in the US, a claims analysis to inform clinical trial background rates
    Presenting Author: Xinyue Liu, PhD, MS – Regeneron Pharmaceuticals, Inc.,
    Co-Author: Bryan Young, MD – Regeneron Pharmaceuticals, Inc.,
    Co-Author: Mazhar Thakur, MD, MBA, MAMM – Regeneron Pharmaceuticals, Inc.,
    Co-Author: Ping Shao, MS – Regeneron Pharmaceuticals, Inc.
    Co-Author: Caitlin Knox – Regeneron
    Pharmacovigilance / Cardiovascular
  • Monday, Aug 25th
    5:15 PM - 5:30 PM ET
    4A-05 - Post-marketing Safety Surveillance of Cardiovascular Risk Among Individuals Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy: A Retrospective Cohort Study
    Presenting Author: Sophie Shen – Bristol Myers Squibb
    Co-Author: Swetha Ramanathan – Stage Analytics
    Co-Author: Jenny Jiang – Bristol Myers Squibb
    Co-Author: Francine Chingcuanco – Stage Analytics
    Co-Author: Omar Mansour – Stage Analytics
    Co-Author: Tamara Lesperance, MPH – Bristol Myers Squibb
    Co-Author: G. Caleb Alexander, MD, MS – Johns Hopkins University, Department of Epidemiology
    Pharmacovigilance / Cardiovascular
  • Tuesday, Aug 26th
    8:30 AM - 8:45 AM ET
    5D-01 - Post-Marketing Safety Analysis of Timolol in Real-World Settings Using Bioinformatics and Disproportionality Analysis with FDA Adverse Event Reporting System (FAERS) Data
    Presenting Author: Shravanth R M, M Pharm – Department of Pharmacy Practice, M S Ramaiah University of Applied Sciences
    Co-Author: Abdul Mannan Faruk Ahmed, M Pharm – Department of Pharmacy Practice, M S Ramaiah University of Applied Sciences
    Co-Author: Eswaran Maheswari – Department of Pharmacy Practice, M S Ramaiah University of Applied Sciences
    Co-Author: Rakshitha N, M Pharm – Department of Pharmaceutical Chemistry, M S Ramaiah University of Applied Sciences
    Pharmacovigilance / Cardiovascular